September 2024's Top SEHK Value Picks For Potential Growth

In This Article:

As global markets react to the recent U.S. Federal Reserve rate cut, Hong Kong's Hang Seng Index has seen a notable uptick, gaining 5.12% in a holiday-shortened week. This positive momentum presents an opportune moment to explore undervalued stocks that could offer significant growth potential. In the current market environment, identifying good stocks involves looking for companies with strong fundamentals and attractive valuations that may benefit from broader economic trends and monetary easing policies.

Top 10 Undervalued Stocks Based On Cash Flows In Hong Kong

Name

Current Price

Fair Value (Est)

Discount (Est)

Yadea Group Holdings (SEHK:1585)

HK$12.16

HK$23.14

47.5%

Hangzhou SF Intra-city Industrial (SEHK:9699)

HK$10.78

HK$20.18

46.6%

BYD (SEHK:1211)

HK$248.80

HK$460.85

46%

Tencent Holdings (SEHK:700)

HK$402.20

HK$772.22

47.9%

Innovent Biologics (SEHK:1801)

HK$41.40

HK$80.59

48.6%

Digital China Holdings (SEHK:861)

HK$3.15

HK$6.01

47.6%

Jinke Smart Services Group (SEHK:9666)

HK$7.44

HK$13.78

46%

DPC Dash (SEHK:1405)

HK$67.00

HK$133.50

49.8%

AK Medical Holdings (SEHK:1789)

HK$4.38

HK$8.40

47.8%

Weimob (SEHK:2013)

HK$1.36

HK$2.59

47.5%

Click here to see the full list of 29 stocks from our Undervalued SEHK Stocks Based On Cash Flows screener.

Let's uncover some gems from our specialized screener.

DPC Dash

Overview: DPC Dash Ltd, with a market cap of HK$8.74 billion, operates a chain of fast-food restaurants in the People’s Republic of China through its subsidiaries.

Operations: The company's revenue primarily comes from its fast-food restaurant operations in the People’s Republic of China, generating CN¥3.72 billion.

Estimated Discount To Fair Value: 49.8%

DPC Dash is trading at HK$67, significantly below its estimated fair value of HK$133.5, indicating it might be undervalued based on cash flows. The company has shown consistent earnings growth of 34.4% per year over the past five years and forecasts revenue growth of 24.9% annually, outpacing the Hong Kong market's average growth rate. Recent inclusion in the S&P Global BMI Index and robust half-year sales figures underscore its strong financial performance and potential for future profitability within three years.

SEHK:1405 Discounted Cash Flow as at Sep 2024
SEHK:1405 Discounted Cash Flow as at Sep 2024

AK Medical Holdings

Overview: AK Medical Holdings Limited designs, develops, produces, and markets orthopedic joint implants and related products in China and internationally with a market cap of HK$4.92 billion.